rtki cpd has been researched along with chloroquine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Evans, LA; Lewis, M; Lindqvist, S; Parris, A; Reynolds, A; Sharp, P; Tighe, R; Williams, MR | 1 |
2 other study(ies) available for rtki cpd and chloroquine
| Article | Year |
|---|---|
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Dynamic and differential regulation of NKCC1 by calcium and cAMP in the native human colonic epithelium.
Topics: Acetylcholine; Adult; Aged; Aged, 80 and over; Calcium; Calcium Signaling; Chloroquine; Cholinergic Agents; Colforsin; Colon; Cyclic AMP; ErbB Receptors; Humans; Intestinal Mucosa; Lysosomes; Middle Aged; Protein Synthesis Inhibitors; Quinazolines; Receptor, Muscarinic M3; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2; Tissue Distribution; Tyrphostins | 2007 |